e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Non-inflammatory monitoring of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum microbiology in patients with stabile COPD
Vanya Kostadinova (Varna, Bulgaria), Vanya Kostadinova, Yordan Radkov, Temenuga Stoeva, Darina Miteva, Anna Dyakova
Source:
International Congress 2015 – Non-inflammatory monitoring of airway diseases
Session:
Non-inflammatory monitoring of airway diseases
Session type:
Thematic Poster Session
Number:
2532
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vanya Kostadinova (Varna, Bulgaria), Vanya Kostadinova, Yordan Radkov, Temenuga Stoeva, Darina Miteva, Anna Dyakova. Sputum microbiology in patients with stabile COPD. Eur Respir J 2015; 46: Suppl. 59, 2532
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Bronchiectasis prevalence and relationship with clinical features in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Impact of bronchiectasis on the course of COPD
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Infective exacerbations of COPD. Relation between the bacteriologic etiology and severity of the disease
Source: International Congress 2014 – COPD markers
Year: 2014
COPD and pneumonia
Source: International Congress 2015 – Different data in COPD
Year: 2015
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Diagnosis confirmation and staging in patients hospitalized with diagnosis of COPD in a general hospital with adequate resources
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Role of bronchoscopy in treatment of plastic bronchitis
Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more
Year: 2013
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012
Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics
Source: International Congress 2015 – Different data in COPD
Year: 2015
Pulmonary rehabilitation in COPD and other chronic lung diseases
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Bacterial resistance induction with prophylactic antibiotics in COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Exacerbations and healthcare resource utilization among COPD patients in Sweden
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept